12/3
08:00 am
biaf
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable
Medium
Report
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable
11/14
08:00 am
biaf
bioAffinity Technologies Reports Third Quarter 2025 Financial Results
Medium
Report
bioAffinity Technologies Reports Third Quarter 2025 Financial Results
11/5
08:00 am
biaf
bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume
Medium
Report
bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume
10/28
08:00 am
biaf
bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases
Medium
Report
bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases
10/20
08:00 am
biaf
bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025
Low
Report
bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025
10/16
08:09 pm
biaf
bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer [Yahoo! Finance]
Low
Report
bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer [Yahoo! Finance]
10/16
08:00 am
biaf
bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer
High
Report
bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer
10/15
08:00 am
biaf
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements
Medium
Report
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements
10/9
02:00 pm
biaf
WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
Low
Report
WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
10/9
01:00 pm
biaf
bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
Low
Report
bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
10/8
03:59 pm
biaf
bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules [Yahoo! Finance]
Neutral
Report
bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules [Yahoo! Finance]
10/8
03:45 pm
biaf
bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
Low
Report
bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
10/8
12:15 pm
biaf
bioAffinity Technologies (NASDAQ:BIAF) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
bioAffinity Technologies (NASDAQ:BIAF) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/7
08:47 am
biaf
bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025 [Yahoo! Finance]
Medium
Report
bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025 [Yahoo! Finance]
10/7
08:00 am
biaf
bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025
Medium
Report
bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025
9/30
12:44 pm
biaf
WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8m
Low
Report
WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8m
9/30
12:43 pm
biaf
bioAffinity Technologies Announces Closing of $4.8 Million Public Offering [Yahoo! Finance]
Low
Report
bioAffinity Technologies Announces Closing of $4.8 Million Public Offering [Yahoo! Finance]
9/30
12:15 pm
biaf
bioAffinity Technologies Announces Closing of $4.8 Million Public Offering
Medium
Report
bioAffinity Technologies Announces Closing of $4.8 Million Public Offering
9/29
04:06 pm
biaf
bioAffinity Technologies Announces Pricing of $4.8 Million Public Offering [Yahoo! Finance]
Medium
Report
bioAffinity Technologies Announces Pricing of $4.8 Million Public Offering [Yahoo! Finance]
9/29
03:51 pm
biaf
bioAffinity Technologies Announces Pricing of $4.8 Million Public Offering
High
Report
bioAffinity Technologies Announces Pricing of $4.8 Million Public Offering
9/26
08:27 am
biaf
bioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath® Lung [Yahoo! Finance]
High
Report
bioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath® Lung [Yahoo! Finance]
9/26
08:00 am
biaf
bioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath® Lung
High
Report
bioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath® Lung
9/20
01:09 am
biaf
bioAffinity Technologies (NASDAQ:BIAF) was downgraded by analysts at
Wal
Medium
Report
bioAffinity Technologies (NASDAQ:BIAF) was downgraded by analysts at
Wal
9/17
08:15 am
biaf
bioAffinity Technologies Announces 1-for-30 Reverse Stock Split Effective at the Open of Trading on September 19, 2025
High
Report
bioAffinity Technologies Announces 1-for-30 Reverse Stock Split Effective at the Open of Trading on September 19, 2025
9/15
10:39 am
biaf
BC-Most Active Stocks [Yahoo! Finance]
Medium
Report
BC-Most Active Stocks [Yahoo! Finance]